SOURCE: Graymark Healthcare, Inc.

Graymark Healthcare, Inc.

February 27, 2012 16:05 ET

Graymark Healthcare to Present at the ROTH Capital Partners 24th Annual Conference on March 14, 2012

OKLAHOMA CITY, OK--(Marketwire - Feb 27, 2012) - Graymark Healthcare, Inc. (NASDAQ: GRMH), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), has been invited to present at the ROTH Capital Partners 24th Annual Conference. The conference will be held at The Ritz Carlton in Laguna Niguel, California on March 12-14, 2012.

Graymark CEO Stanton Nelson is scheduled to present on Wednesday, March 14, 2012 at 3:00 p.m. Pacific time with one-on-one meetings held throughout the day.

The presentation will be broadcast simultaneously and available for replay at http://wsw.com/webcast/roth26/grmh/ and on Graymark's website at www.graymarkhealthcare.com.

For more information about the conference or to schedule a one-on-one meeting with Graymark's management, please contact your ROTH representative at 1-800-933-6830 or conference@roth.com.

About ROTH Capital Partners, LLC

ROTH Capital Partners is a relationship-driven investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity securities of companies based in the U.S. and China. Headquartered in Newport Beach, CA, with offices throughout the U.S., Hong Kong and a Shanghai Representative Office, the employee-owned firm provides analytical research, trading, capital raising, and business combination advisory services. ROTH seeks to implement innovative financing strategies to efficiently meet the liquidity and valuation requirements of both its corporate and institutional investor clients. For more information, go to www.roth.com.

About Graymark Healthcare

Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (NASDAQ: GRMH) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 101 sleep laboratories primarily in the Midwest, including standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements. For more information, visit www.graymarkhealthcare.com.

Important Cautions Regarding Forward-Looking Statements

This press release contains forward-looking statements that are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the risk that the transaction does not close as planned or at all, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at www.sec.gov. Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Company Contact:
    Graymark Healthcare, Inc.
    Stanton Nelson
    Chairman and CEO
    Tel 405-601-5300

    Investor Relations:
    Liolios Group, Inc.
    Scott Liolios or Cody Slach
    Tel 949-574-3860
    Email Contact